{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T20:52:50Z","timestamp":1776459170347,"version":"3.51.2"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"DOI":"10.1007\/s00011-026-02245-2","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T20:00:14Z","timestamp":1776456014000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tm4sf19 inhibition alleviates imiquimod-induced psoriatic dermatitis by regulating inflammatory signaling pathways and keratinocyte proliferation in mice"],"prefix":"10.1007","volume":"75","author":[{"given":"Min Gi","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujin","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eunji","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Jung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da Seul","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Sun","family":"Heo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haein","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naim","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeyeon","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pyunggang","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minjung","family":"Son","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoungwha","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinah","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ga-Eun","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong Jung","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiya","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seok Hee","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"2245_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1286344","volume":"14","author":"M Kamata","year":"2023","unstructured":"Kamata M, Tada Y. Crosstalk: keratinocytes and immune cells in psoriasis. Front Immunol. 2023;14:1286344.","journal-title":"Front Immunol"},{"issue":"1","key":"2245_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","volume":"13","author":"X Zhou","year":"2022","unstructured":"Zhou X, Chen Y, Cui L, Shi Y, Guo C. Advances in the pathogenesis of psoriasis: from keratinocyte perspective. Cell Death Dis. 2022;13(1):81.","journal-title":"Cell Death Dis"},{"key":"2245_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.773280","volume":"12","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Shi Y, Lin J, Li X, Yang B, Zhou J. Immune cell infiltration analysis demonstrates excessive mast cell activation in psoriasis. Front Immunol. 2021;12:773280.","journal-title":"Front Immunol"},{"key":"2245_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111574","author":"M Vicic","year":"2021","unstructured":"Vicic M, Kastelan M, Brajac I, Sotosek V, Massari LP. Current concepts of psoriasis immunopathogenesis. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms222111574.","journal-title":"Int J Mol Sci"},{"key":"2245_CR5","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","volume":"32","author":"MA Lowes","year":"2014","unstructured":"Lowes MA, Su\u00e1rez-Fari\u00f1as M, Krueger JG. Immunology of psoriasis. Annu Rev Immunol. 2014;32:227\u201355.","journal-title":"Annu Rev Immunol"},{"key":"2245_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.941071","volume":"13","author":"M Kamata","year":"2022","unstructured":"Kamata M, Tada Y. Dendritic cells and macrophages in the pathogenesis of psoriasis. Front Immunol. 2022;13:941071.","journal-title":"Front Immunol"},{"key":"2245_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25105306","author":"K Nazimek","year":"2024","unstructured":"Nazimek K, Bryniarski K. Macrophage functions in psoriasis: lessons from mouse models. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25105306.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2245_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12950-023-00360-z","volume":"20","author":"T Xia","year":"2023","unstructured":"Xia T, Fu S, Yang R, Yang K, Lei W, Yang Y, et al. Advances in the study of macrophage polarization in inflammatory immune skin diseases. J Inflamm Lond. 2023;20(1):33.","journal-title":"J Inflamm Lond"},{"issue":"10","key":"2245_CR9","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/nrm1736","volume":"6","author":"ME Hemler","year":"2005","unstructured":"Hemler ME. Tetraspanin functions and associated microdomains. Nat Rev Mol Cell Biol. 2005;6(10):801\u201311.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"12","key":"2245_CR10","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/0167-5699(94)90222-4","volume":"15","author":"MD Wright","year":"1994","unstructured":"Wright MD, Tomlinson MG. The ins and outs of the transmembrane 4 superfamily. Immunol Today. 1994;15(12):588\u201394.","journal-title":"Immunol Today"},{"issue":"9","key":"2245_CR11","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.tcb.2009.06.004","volume":"19","author":"M Yanez-Mo","year":"2009","unstructured":"Yanez-Mo M, Barreiro O, Gordon-Alonso M, Sala-Valdes M, Sanchez-Madrid F. Tetraspanin-enriched microdomains: a functional unit in cell plasma membranes. Trends Cell Biol. 2009;19(9):434\u201346.","journal-title":"Trends Cell Biol"},{"issue":"3","key":"2245_CR12","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1042\/BST20160284","volume":"45","author":"SJ van Deventer","year":"2017","unstructured":"van Deventer SJ, Dunlock VE, van Spriel AB. Molecular interactions shaping the tetraspanin web. Biochem Soc Trans. 2017;45(3):741\u201350.","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"2245_CR13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41413-025-00419-y","volume":"13","author":"S Park","year":"2025","unstructured":"Park S, Yoon K, Hong E, Kim MW, Kang MG, Mizuno S, et al. Tm4sf19 inhibition ameliorates inflammation and bone destruction in collagen-induced arthritis by suppressing TLR4-mediated inflammatory signaling and abnormal osteoclast activation. Bone Res. 2025;13(1):40.","journal-title":"Bone Res"},{"key":"2245_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155746","volume":"151","author":"S Park","year":"2024","unstructured":"Park S, Heo JS, Mizuno S, Kim M, An H, Hong E, et al. Tm4sf19 deficiency inhibits osteoclast multinucleation and prevents bone loss. Metabolism. 2024;151:155746.","journal-title":"Metabolism"},{"issue":"1","key":"2245_CR15","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13059-014-0570-4","volume":"16","author":"LC Tsoi","year":"2015","unstructured":"Tsoi LC, Iyer MK, Stuart PE, Swindell WR, Gudjonsson JE, Tejasvi T, et al. Analysis of long non-coding RNAs highlights tissue-specific expression patterns and epigenetic profiles in normal and psoriatic skin. Genome Biol. 2015;16(1):24.","journal-title":"Genome Biol"},{"issue":"2","key":"2245_CR16","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/ni.3643","volume":"18","author":"Y Liang","year":"2017","unstructured":"Liang Y, Tsoi LC, Xing X, Beamer MA, Swindell WR, Sarkar MK, et al. A gene network regulated by the transcription factor VGLL3 as a promoter of sex-biased autoimmune diseases. Nat Immunol. 2017;18(2):152\u201360.","journal-title":"Nat Immunol"},{"key":"2245_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/cells11182904","author":"G Rioux","year":"2022","unstructured":"Rioux G, Turgeon F, Le-Bel G, Grenier C, Guerin SL, Pouliot R. Gene profiling of a 3D psoriatic skin model enriched in T cells: downregulation of PTPRM promotes keratinocyte proliferation through excessive ERK1\/2 signaling. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11182904.","journal-title":"Cells"},{"key":"2245_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1265517","volume":"14","author":"Y Gao","year":"2023","unstructured":"Gao Y, Na M, Yao X, Li C, Li L, Yang G, et al. Integrative single-cell transcriptomic investigation unveils long non-coding RNAs associated with localized cellular inflammation in psoriasis. Front Immunol. 2023;14:1265517.","journal-title":"Front Immunol"},{"issue":"5 Suppl 93","key":"2245_CR19","first-page":"S14","volume":"33","author":"V Oji","year":"2015","unstructured":"Oji V, Luger TA. The skin in psoriasis: assessment and challenges. Clin Exp Rheumatol. 2015;33(5 Suppl 93):S14\u20139.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"2245_CR20","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s41420-023-01444-8","volume":"9","author":"RZ Tan","year":"2023","unstructured":"Tan RZ, Zhong X, Han RY, Xie KH, Jia J, Yang Y, et al. Macrophages mediate psoriasis via Mincle-dependent mechanism in mice. Cell Death Discov. 2023;9(1):140.","journal-title":"Cell Death Discov"},{"issue":"8","key":"2245_CR21","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"KV Swanson","year":"2019","unstructured":"Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19(8):477\u201389.","journal-title":"Nat Rev Immunol"},{"key":"2245_CR22","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.121175","author":"R Matsumoto","year":"2018","unstructured":"Matsumoto R, Dainichi T, Tsuchiya S, Nomura T, Kitoh A, Hayden MS, et al. Epithelial TRAF6 drives IL-17-mediated psoriatic inflammation. JCI Insight. 2018. https:\/\/doi.org\/10.1172\/jci.insight.121175.","journal-title":"JCI Insight"},{"issue":"3","key":"2245_CR23","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1189\/jlb.3MA0217-054RR","volume":"102","author":"S Costa","year":"2017","unstructured":"Costa S, Marini O, Bevilacqua D, DeFranco AL, Hou B, Lonardi S, et al. Role of MyD88 signaling in the imiquimod-induced mouse model of psoriasis: focus on innate myeloid cells. J Leukoc Biol. 2017;102(3):791\u2013803.","journal-title":"J Leukoc Biol"},{"key":"2245_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00461","volume":"5","author":"T Kawasaki","year":"2014","unstructured":"Kawasaki T, Kawai T. Toll-like receptor signaling pathways. Front Immunol. 2014;5:461.","journal-title":"Front Immunol"},{"key":"2245_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02376","volume":"10","author":"CC Chiang","year":"2019","unstructured":"Chiang CC, Cheng WJ, Korinek M, Lin CY, Hwang TL. Neutrophils in psoriasis. Front Immunol. 2019;10:2376.","journal-title":"Front Immunol"},{"issue":"1","key":"2245_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38390-z","volume":"14","author":"MG Sugiyama","year":"2023","unstructured":"Sugiyama MG, Brown AI, Vega-Lugo J, Borges JP, Scott AM, Jaqaman K, et al. Confinement of unliganded EGFR by tetraspanin nanodomains gates EGFR ligand binding and signaling. Nat Commun. 2023;14(1):2681.","journal-title":"Nat Commun"},{"issue":"9364","key":"2245_CR27","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/S0140-6736(03)12954-6","volume":"361","author":"M Lebwohl","year":"2003","unstructured":"Lebwohl M. Psoriasis. Lancet. 2003;361(9364):1197\u2013204.","journal-title":"Lancet"},{"issue":"6","key":"2245_CR28","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1684\/ejd.2016.2932","volume":"26","author":"E Mahe","year":"2016","unstructured":"Mahe E. Childhood psoriasis. Eur J Dermatol. 2016;26(6):537\u201348.","journal-title":"Eur J Dermatol"},{"issue":"10281","key":"2245_CR29","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker J. Psoriasis. Lancet. 2021;397(10281):1301\u201315.","journal-title":"Lancet"},{"issue":"9","key":"2245_CR30","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1016\/j.jid.2021.02.764","volume":"141","author":"D Yan","year":"2021","unstructured":"Yan D, Gudjonsson JE, Le S, Maverakis E, Plazyo O, Ritchlin C, et al. New frontiers in psoriatic disease research, Part I: genetics, environmental triggers, immunology, pathophysiology, and precision medicine. J Invest Dermatol. 2021;141(9):2112-22 e3.","journal-title":"J Invest Dermatol"},{"issue":"4","key":"2245_CR31","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/bjd.18245","volume":"182","author":"NJ Korman","year":"2020","unstructured":"Korman NJ. Management of psoriasis as a systemic disease: what is the evidence? Br J Dermatol. 2020;182(4):840\u20138.","journal-title":"Br J Dermatol"},{"issue":"12","key":"2245_CR32","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1038\/jid.2011.222","volume":"131","author":"X Shi","year":"2011","unstructured":"Shi X, Jin L, Dang E, Chang T, Feng Z, Liu Y, et al. IL-17A upregulates keratin 17 expression in keratinocytes through STAT1- and STAT3-dependent mechanisms. J Invest Dermatol. 2011;131(12):2401\u20138.","journal-title":"J Invest Dermatol"},{"issue":"3","key":"2245_CR33","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jdermsci.2012.06.008","volume":"67","author":"M Fu","year":"2012","unstructured":"Fu M, Wang G. Keratin 17 as a therapeutic target for the treatment of psoriasis. J Dermatol Sci. 2012;67(3):161\u20135.","journal-title":"J Dermatol Sci"},{"issue":"11","key":"2245_CR34","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.7150\/ijbs.83141","volume":"19","author":"Y Luo","year":"2023","unstructured":"Luo Y, Pang B, Hao J, Li Q, Qiao P, Zhang C, et al. Keratin 17 covalently binds to alpha-enolase and exacerbates proliferation of keratinocytes in psoriasis. Int J Biol Sci. 2023;19(11):3395\u2013411.","journal-title":"Int J Biol Sci"},{"issue":"7","key":"2245_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040797","volume":"7","author":"W Zhang","year":"2012","unstructured":"Zhang W, Dang E, Shi X, Jin L, Feng Z, Hu L, et al. The pro-inflammatory cytokine IL-22 up-regulates keratin 17 expression in keratinocytes via STAT3 and ERK1\/2. PLoS ONE. 2012;7(7):e40797.","journal-title":"PLoS ONE"},{"issue":"2","key":"2245_CR36","first-page":"520","volume":"11","author":"S Wang","year":"2019","unstructured":"Wang S, Zhang Z, Peng H, Zeng K. Recent advances on the roles of epidermal growth factor receptor in psoriasis. Am J Transl Res. 2019;11(2):520\u20138.","journal-title":"Am J Transl Res"},{"issue":"6","key":"2245_CR37","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.4049\/jimmunol.1800013","volume":"201","author":"JE Hawkes","year":"2018","unstructured":"Hawkes JE, Yan BY, Chan TC, Krueger JG. Discovery of the IL-23\/IL-17 signaling pathway and the treatment of psoriasis. J Immunol. 2018;201(6):1605\u201313.","journal-title":"J Immunol"},{"issue":"1","key":"2245_CR38","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/jid.2012.194","volume":"133","author":"DA Martin","year":"2013","unstructured":"Martin DA, Towne JE, Kricorian G, Klekotka P, Gudjonsson JE, Krueger JG, et al. The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings. J Invest Dermatol. 2013;133(1):17\u201326.","journal-title":"J Invest Dermatol"},{"issue":"19","key":"2245_CR39","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA. 2020;323(19):1945\u201360.","journal-title":"JAMA"},{"issue":"10275","key":"2245_CR40","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","volume":"397","author":"K Ghoreschi","year":"2021","unstructured":"Ghoreschi K, Balato A, Enerback C, Sabat R. Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis. Lancet. 2021;397(10275):754\u201366.","journal-title":"Lancet"},{"key":"2245_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713313","author":"HJ Lee","year":"2023","unstructured":"Lee HJ, Kim M. Challenges and future trends in the treatment of psoriasis. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241713313.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2245_CR42","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1590\/abd1806-4841.20175603","volume":"92","author":"J Vide","year":"2017","unstructured":"Vide J, Magina S. Moderate to severe psoriasis treatment challenges through the era of biological drugs. An Bras Dermatol. 2017;92(5):668\u201374.","journal-title":"An Bras Dermatol"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02245-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-026-02245-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02245-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T20:00:15Z","timestamp":1776456015000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-026-02245-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2245"],"URL":"https:\/\/doi.org\/10.1007\/s00011-026-02245-2","relation":{},"ISSN":["1420-908X"],"issn-type":[{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"31 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"S.J.K. is the founder of Medpacto and serves on its Board of Directors.\u00a0M.J.L., M.W.K., N. P., and S.J.K. are employees of Medpacto. The GILO Foundation has received research support from Medpacto. The other authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"97"}}